Grantham, Mayo, Van Otterloo & Co (GMO)
GWPH

Grantham, Mayo, Van Otterloo & Co (GMO)’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-334,864
Closed -$72.6M – 901
2021
Q1 		$72.6M Buy
+334,864
New +$62.9M 0.4% 52

Other funds holding GWPH

HDIM
Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s GWPH Position: Q2 2021 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 334,864 shares — an estimated $72.6M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in GWPH in Q1 2021 and held it in 1 quarter. The position peaked at $72.6M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 334,864 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $72.6M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2021 and held it in 1 quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s GW Pharmaceuticals Plc American Depositary Shares position peaked at $72.6M in Q1 2021.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2021, filed 12 Aug 2021.